<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An 83-year-old woman received a diagnosis of moderate <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in November 1990 </plain></SENT>
<SENT sid="1" pm="."><plain>Immunosuppressive therapy consisting of anti-lymphocyte globulin combined with high-dose <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> was effective until <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> developed in August 1993 </plain></SENT>
<SENT sid="2" pm="."><plain>The patient was hospitalized again and recurrence of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> was diagnosed on the basis of hematologic findings, including RBC 129 x 10(4)/microliter, Hb 5.5 g/dl, Ret 23,200/microliter, WBC 2,200/microliter with 27% neutrophils, platelets 2.2 x 10(4)/microliter, and <z:hpo ids='HP_0005528'>hypoplastic bone marrow</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Recombinant human granulocyte-colony stimulating factor (G-CSF) of 125 micrograms/day combined with recombinant human erythropoietin (EPO) of 6,000 U/day were started in November 1993 </plain></SENT>
<SENT sid="4" pm="."><plain>The doses of G-CSF and EPO were increased to 250 micrograms/day and 12,000 U/day, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>We stopped combination therapy in March 1995, after trilineage hematopoietic cell recovery had been achieved </plain></SENT>
<SENT sid="6" pm="."><plain>Complete recovery in peripheral blood was sustained for more than 2 years despite the termination of G-CSF and EPO therapy </plain></SENT>
<SENT sid="7" pm="."><plain>Combination therapy with G-CSF and EPO may be safe and effective for elderly patients with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> when the choice of therapy is limited </plain></SENT>
</text></document>